Inventor · disambiguated record
Queenie Vong
Also filed as: VONG QUEENIE · VONG QUEENIE M
3 granted patents·8 pending applications·1 citations·filing 2018–2025
50Inventor score
Top patents by PatentIndex Score
11 records- 0172US11952408B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 9, 2024·1 cites·46 claims
- 0266US12270032B2Codon-optimized nucleotide sequences encoding an AP-1 transcription factorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 0361US12144827B2ROR1 targeting chimeric antigen receptorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 0455US2025297268A1Codon-optimized nucleotide sequences encoding an ap-1 transcription factorLYELL IMMUNOPHARMA INC·Filed 2025·Application pending·0 cites
- 0551US2023313138A1Methods for culturing cells expressing c-junLYELL IMMUNOPHARMA INC·Filed 2022·Application pending·0 cites
- 0651US2023310605A1Methods for culturing cells expressing ror1-binding proteinLYELL IMMUNOPHARMA INC·Filed 2022·Application pending·0 cites
- 0750US2023398216A1Chimeric activation receptorsLYELL IMMUNOPHARMA INC·Filed 2021·Application pending·0 cites
- 0846US2022184131A1Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0942US2021015869A1T cells expressing a recombinant receptor, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1042US2021017249A1Methods of producing cells expressing a recombinant receptor and related compositionsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1141US2023061455A1Methods, compositions and components for crispr-cas9 editing of tgfbr2 in t cells for immunotherapyEDITAS MEDICINE INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →